Valuation: Thor Medical

Market Cap 2.25B 237M 205M 192M 175M 330M 22.59B 335M 2.26B 884M 11.31B 889M 869M 37.72B P/E 2026 *
-44.6x
P/E 2027 * -56.8x
Enterprise Value 2.43B 256M 222M 208M 190M 357M 24.43B 363M 2.45B 956M 12.23B 961M 940M 40.79B EV / Sales 2026 *
49.7x
EV / Sales 2027 * 14.4x
Free-Float
59.77%
Yield 2026 *
-
Yield 2027 * -
1 week+17.92%
Current month+7.94%
1 month+50.06%
3 months+41.88%
6 months+22.31%
Current year+19.05%
1 week 5.45
Extreme 5.45
6.62
1 month 4.2
Extreme 4.195
6.62
Current year 3.88
Extreme 3.88
6.62
1 year 2.52
Extreme 2.515
6.62
3 years 0.85
Extreme 0.85
6.62
5 years 0.85
Extreme 0.85
6.62
10 years 0.85
Extreme 0.85
6.62
Manager TitleAgeSince
Chief Executive Officer 41 2024-07-31
Director of Finance/CFO 37 2023-06-30
Chief Tech/Sci/R&D Officer - 2023-05-31
Director TitleAgeSince
Director/Board Member 67 2023-06-27
Chairman 59 -
Director/Board Member - 2025-04-23
Date Insider Type Main position Quantity % Market Cap.
6/26/25
Scatec Innovation AS
OthersCompany 31,577,399 10.0434%
6/18/25
Scatec Innovation AS
BuyCompany 3,000,000 0.9542%
5/2/25 Fiscal year

Director

164,641 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+17.92%+160.96%+317.22% 241M
+2.07%+13.76%+65.44%+106.53% 70.1B
-0.87%+0.08%+36.96%+65.91% 54.93B
-4.50%-4.69%+2.82%+463.22% 28.89B
+0.04%+10.49%+48.44%+5.47% 23.9B
-0.67%+1.02%-18.32%-13.84% 23.3B
+0.35%+12.02%+257.19%+466.50% 18.41B
-0.59%+7.88%+40.87%-20.56% 18.77B
-0.57%+3.44%+25.60%+580.70% 16.1B
+0.46%-3.05%+31.49%+135.18% 12.48B
Average -0.43%+5.68%+65.14%+210.63% 26.71B
Weighted average by Cap. -0.21%+3.99%+51.57%+163.19%

Financials

2026 *2027 *
Net sales 49M 5.15M 4.47M 4.19M 3.82M 7.19M 492M 7.3M 49.32M 19.25M 246M 19.35M 18.93M 822M 168M 17.67M 15.32M 14.36M 13.09M 24.64M 1.69B 25.03M 169M 66.02M 844M 66.35M 64.92M 2.82B
Net income -49M -5.15M -4.47M -4.19M -3.82M -7.19M -492M -7.3M -49.32M -19.25M -246M -19.35M -18.93M -822M -40M -4.21M -3.65M -3.42M -3.12M -5.87M -402M -5.96M -40.26M -15.72M -201M -15.8M -15.46M -671M
Net Debt 183M 19.25M 16.69M 15.64M 14.26M 26.84M 1.84B 27.27M 184M 71.91M 920M 72.28M 70.71M 3.07B 177M 18.62M 16.14M 15.13M 13.8M 25.96M 1.78B 26.37M 178M 69.55M 890M 69.91M 68.39M 2.97B
Logo Thor Medical
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
Employees
-
Date Price Change Volume
26-08-13 NOK 6.250 -1.57% 6,151,779
26-08-12 NOK 6.350 +4.10% 6,913,053
26-08-11 NOK 6.100 +4.10% 7,889,660
26-08-10 NOK 5.860 +7.92% 6,378,835
26-08-07 NOK 5.430 +2.45% 2,726,028
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
6.250NOK
Average target price
3.500NOK
Spread / Average Target
-44.00%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRMED Stock